Cost-Effectiveness of Afatinib Versus Erlotinib for The Treatment of Squamous Non-Small Cell Lung Cancer in France After A First-Line Platinium Based Therapy

Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.210
https://www.valueinhealthjournal.com/article/S1098-3015(17)30544-2/fulltext
Title : Cost-Effectiveness of Afatinib Versus Erlotinib for The Treatment of Squamous Non-Small Cell Lung Cancer in France After A First-Line Platinium Based Therapy
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30544-2&doi=10.1016/j.jval.2017.08.210
First page : A434
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 190
Categories :
Tags :
Regions :
ViH Article Tags :